Lv1
80 积分 2023-11-27 加入
FMO2 ameliorates nonalcoholic fatty liver disease by suppressing ER-to-Golgi transport of SREBP1
4天前
求助中
FMO2 ameliorates nonalcoholic fatty liver disease by suppressing ER-to-Golgi transport of SREBP1
5天前
已关闭
Insights on post-translational modifications in fatty liver and fibrosis progression
5天前
已完结
FMO2 ameliorates nonalcoholic fatty liver disease by suppressing ER-to-Golgi transport of SREBP1
1个月前
已完结
Targeting PYK2 with heterobifunctional T6BP helps mitigate MASLD and MASH-HCC progression
1个月前
已完结
Targeting EFHD2 inhibits interferon-γ signaling and ameliorates non-alcoholic steatohepatitis
4个月前
已完结
Targeting EFHD2 inhibits interferon-γ signaling and ameliorates non-alcoholic steatohepatitis
4个月前
已完结
The Antiobesity Effects and Potential Mechanisms of Theaflavins
6个月前
已完结
Hepatic IL22RA1 deficiency promotes hepatic steatosis by modulating oxysterol in the liver
9个月前
已完结
Hepatic malonyl-CoA synthesis restrains gluconeogenesis by suppressing fat oxidation, pyruvate carboxylation, and amino acid availability
10个月前
已完结
皖公网安备34019202002308
